```json
{
"content": [
{
"type": "paragraph",
"content": "North America remains the largest Herbal Supplement for Mental Health market, underpinned by 45% consumer adoption, robust FDA-registered manufacturing, and insurer pilot reimbursement for botanical anxiolytics; regional forecast CAGR 7.8% through 2028 is propelled by millennial self-care spending and digital DTC channels."
},
{
"type": "paragraph",
"content": "Europe, valued at USD 1.9 B in 2023, is the fastest-growing region (9.1% CAGR) as EFSA positive monographs for saffron and lemon balm coincide with EU4Health earmarked €550 M for integrative mental-health pilots; Germany and Nordic markets lead, leveraging pharmacy-grade extraction infrastructure and decriminalised medical cannabis ecosystems that de-risk new botanical entrants."
},
{
"paragraph",
"content": "Asia Pacific benefits from Ayurveda and TCM legitimisation—India’s AYUSH Ministry allocates $1.2 B while China’s cross-border e-commerce zones slash time-to-market from 18 to 6 months; rising 55+ cohort and urban pollution anxiety drive per-capita spend on adaptogens up 14% YoY, fuelling Herbal Supplement for Mental Health market growth."
},
{
"type": "paragraph",
"content": "Latin America shows 11% YoY Amazon-derived ingredient exports and progressive Brazilian ANVISA fast-track listings; however, currency volatility keeps CAGR at 6.4%. Middle East & Africa, though nascent, sees 21% public-private investment uplift in UAE and South African GMP corridors, positioning the Gulf as a future formulation hub."
}
],
"worldMapData": {
"regions": [
{ "name": "North America", "value": 35 },
{ "name": "Europe", "value": 28 },
{ "name": "Asia Pacific", "value": 22 },
{ "name": "Latin America", "value": 8 },
{ "name": "Middle East & Africa", "value": 7 }
]
}
}
```
